MARKET

ASXC

ASXC

Asensus Surgical Inc
AMEX

Real-time Quotes | Nasdaq Last Sale

0.8400
+0.0199
+2.43%
After Hours: 0.8500 +0.01 +1.19% 17:55 01/24 EST
OPEN
0.8037
PREV CLOSE
0.8201
HIGH
0.8400
LOW
0.7300
VOLUME
5.63M
TURNOVER
--
52 WEEK HIGH
6.95
52 WEEK LOW
0.7300
MARKET CAP
196.89M
P/E (TTM)
-2.4547
1D
5D
1M
3M
1Y
5Y
Asensus Surgical trades in green on prelim FY21 corporate update
In its prelim 2021 year-end corporate update, Asensus Surgical (NYSE:ASXC) reported 500+ procedures performed globally during Q4 (+25% Y/Y) while 2K+ procedures were performed globally (+42% Y/Y). Six Senhance Surgical Programs
Seekingalpha · 01/10 12:33
BRIEF-Asensus Surgical Sees FY Revenue About $7.9 Million To $8.3 Million
reuters.com · 01/10 11:51
Asensus Surgical Provides Preliminary 2021 Year-End Corporate Update
RESEARCH TRIANGLE PARK, N.C., January 10, 2022--Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today provided ...
Business Wire · 01/10 11:50
RIOT, MARA and ASXC among pre market gainers
Reliance Global (NASDAQ:RELI) +85%. Aridis Pharmaceuticals (NASDAQ:ARDS) +72% after its antibody cocktail retains effectiveness against Omicron variant. Quoin Pharmaceuticals (NASDAQ:QNRX) +44%. Cassava Sciences (NASDAQ:SAVA) +40% Cassava Sciences, Biofron...
Seekingalpha · 12/21/2021 13:23
Asensus Surgical Granted U.S. Patent #11,199,545 'Hydraulic instrument drive system for minimally invasive surgery'
View Patent Here
Benzinga · 12/14/2021 11:19
Asensus Surgical Announces Purchase Of Senhance Robotic System By RZD Medicine; No Terms Disclosed
Asensus Surgical, Inc. (NYSE:ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced Private
Benzinga · 11/29/2021 11:55
55 Stocks Moving In Thursday's Mid-Day Session
Gainers Evaxion Biotech A/S (NASDAQ: EVAX) shares climbed 179% to $18.17 after dropping over 10% on Wednesday.
Benzinga · 11/04/2021 16:25
Asensus Surgical Posts Narrower Q3 Loss, Higher Revenue; Shares Rise Pre-Bell
MT Newswires · 11/04/2021 06:15
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of ASXC. Analyze the recent business situations of Asensus Surgical Inc through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

0.00%Strong Buy
100.00%Buy
0.00%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average ASXC stock price target is 4.000 with a high estimate of 4.000 and a low estimate of 4.000.
High4.000
Average4.000
Low4.000
Current 0.8400
EPS
Actual
Estimate
-0.09-0.07-0.04-0.02
Q4 2020
Q1 2021
Q2 2021
Q3 2021
Q4 2021
Institutional Holdings
Institutions: 157
Institutional Holdings: 73.36M
% Owned: 31.30%
Shares Outstanding: 234.39M
TypeInstitutionsShares
Increased
45
6.91M
New
19
2.21M
Decreased
31
11.32M
Sold Out
24
1.40M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
+0.10%
Healthcare Equipment & Supplies
-0.18%
Key Executives
Chairman/Director
David Milne
President/Chief Executive Officer/Director
Anthony Fernando
Chief Financial Officer/Executive Vice President
Shameze Rampertab
Independent Director
Andrea Biffi
Independent Director
Kevin Hobert
Independent Director
Jane Hsiao
Independent Director
Elizabeth Kwo
Independent Director
Richard Pfenniger
Independent Director
William Starling
No Data
About ASXC
Asensus Surgical, Inc., formerly TransEnterix, Inc., is a medical device company. The Company is engaged in digitizing the interface between the surgeon and the patient to improve minimally invasive surgery (MIS) through digital laparoscopy. The Senhance system is a machine vision system for use in robotic surgery, which is powered by intelligent surgical unit that enables augmented intelligence in surgery. Its System is designed to maintain laparoscopic MIS standards while providing digital benefits such as haptic feedback, advanced instrumentation, including three-millimeter micro laparoscopic instruments, eye-sensing camera control and reusable standard instruments to patients around the world. The Senhance System is used in Europe for laparoscopic abdominal and pelvic surgery, as well as limited thoracic operations. It is also available in the United States, Japan, Taiwan and Russia.

Webull offers kinds of Asensus Surgical Inc stock information, including AMEX:ASXC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ASXC stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ASXC stock methods without spending real money on the virtual paper trading platform.